The Voltage Dependent T Type Calcium Channel Subunit Alpha 1I pipeline drugs market research report outlays comprehensive information on the Voltage Dependent T Type Calcium Channel Subunit Alpha 1I targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA), and molecule type. GlobalData’s report assesses the drugs in the Voltage Dependent T Type Calcium Channel Subunit Alpha 1I pipeline by therapy areas, indications, stages, MoA, RoA, molecule type and the key players in the development pipeline. Buy the report here.
The report also covers products from therapy areas such as Central Nervous System, and Dermatology which include the indications Alzheimer’s Disease, Epilepsy, and Pruritus. It also reviews key players involved in Voltage Dependent T Type Calcium Channel Subunit Alpha 1I targeted therapeutics development with respective active and dormant or discontinued products.
The Voltage Dependent T Type Calcium Channel Subunit Alpha 1I pipeline targets constitutes close to eight molecules. Out of which, approximately seven molecules are developed by companies and the remaining by the universities/institutes. The molecules developed by companies in Phase II, and Preclinical stages are 2, and 5 respectively. Similarly, the universities portfolio in Preclinical comprises 1 molecule.
Voltage Dependent T Type Calcium Channel Subunit Alpha 1I overview
Voltage-dependent T-type calcium channel subunit alpha-1I (Cav3.3) is involved in forming the ion-conducting pore of T-type calcium channels, contributing to cellular excitability and calcium signalling.
For a complete picture of Voltage Dependent T Type Calcium Channel Subunit Alpha 1I’s drug pipeline, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.